Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06058767 · ClinicalTrials.gov registry record · NA

Preschool Hearing Screening

A NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
13,764
Enrollment target
1
Study location

NCT06058767: Recruiting NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by University of California, San Francisco.

NCT06058767 is a NA study of Hearing Loss and Hearing Loss, Sensorineural that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 13,764 participants, above the 5,884-participant average among 58 other Hearing Loss trials with a reported enrollment target (134% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06058767, a NA study of Hearing Loss and Hearing Loss, Sensorineural, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
13,764 participants
Enrollment target
1
Study location

Study Summary

Children who are deaf or hard-of-hearing (D/HH) are at risk of speech and language delays, which can be mitigated through early identification and intervention. Identifying hearing loss (HL) during preschool is crucial, but the most effective hearing screening method for preschoolers remains uncertain. The purpose of this study is to learn whether, compared to the gold-standard two-stage Pure-tone audiometry (PTA) + otoacoustic emissions (OAE) screening (TS-PO), single-stage OAE (SS-O) screening alone is not inferior at identifying hearing loss when performed in a community-based preschool setting. This study holds the potential to improve early hearing loss detection and intervention among D/HH children, reducing the likelihood of speech and language delays. A diverse group of 13,764 preschool-age children across community-based preschool centers will be recruited. The intervention involves all subjects undergoing both PTA and OAE screening, with the order determined through randomization. Children who show potential hearing issues based on screening results or teacher concerns will receive further testing to determine the final hearing outcome. Group allocation will be post-hoc, based on their screening results. In addition to the primary objective, the study will compare other hearing screening measures and outcomes between the two methods (TS-PO and SS-O). This approach aims to reflect the real-life effectiveness of hearing screening in a diverse population. Ultimately, the study seeks to provide insights into an optimal hearing screening method that could prevent speech and language delays among D/HH children.

Primary Outcome

Percentage of children identified with hearing loss; (number of children identified with hearing loss) / (number of all screened children)

Interventions

  • OTHER Otoacoustic Emissions Testing
  • OTHER Pure Tone Audiometry

Study Locations (1)

California

  • The University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 13,764 participants
Start Date 2023-10-01
Est. Completion 2028-02-01
Phase NA

What NCT06058767 shows while recruiting

NCT06058767 is an interventional study that assigns participants to a tested intervention. Its 13,764 participants enrollment target places it among the larger protocols in the corpus, above the 5,884-participant average among 58 other Hearing Loss trials with a reported enrollment target (134% higher).

The record links to 8 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Otoacoustic Emissions Testing is the first listed.

NCT06058767 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06058767 about?

NCT06058767 is a clinical study titled "Preschool Hearing Screening". Children who are deaf or hard-of-hearing (D/HH) are at risk of speech and language delays, which can be mitigated through early identification and intervention. Identifying hearing loss (HL) during preschool is crucial, but the most effective hearing screening method for preschoolers remains uncerta...

What is the current status of trial NCT06058767?

This trial is currently recruiting. It is a NA study. The enrollment target is 13,764 participants. The study started on 2023-10-01. Estimated completion is 2028-02-01.

What conditions does trial NCT06058767 study?

This clinical trial studies the following conditions: Hearing Loss, Hearing Loss, Sensorineural, Hearing Loss, Bilateral, Hearing Loss, Unilateral, Hearing Loss, Conductive.

What interventions are being tested in trial NCT06058767?

The interventions under investigation include: Otoacoustic Emissions Testing (OTHER), Pure Tone Audiometry (OTHER).

Who is sponsoring clinical trial NCT06058767?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06058767 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06058767's enrollment target sits among peer trials

13,764 3rd of 58 higher than 56 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT05591066 · 14,400 participants · NA

    The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06058767, the US trial registry maintained by the National Library of Medicine. NCT06058767 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.